Market Overview

Trade CNS stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
2/21/19Keefe Bruyette & WoodsDowngradesMarket PerformUnderperform0.0
1/25/19Keefe Bruyette & WoodsUpgradesUnderperformMarket Perform36.0
7/20/18Credit SuisseMaintainsNeutralNeutral41.0
Show more Loading articles...

Earnings View Earnings

Q1 2019 EST Actual Surprise
EPS: 0.55 0.580 0.0300
Rev: 89.30M 94.23M 4.93M
Q2 2019 EST Actual Surprise
EPS: Expected
2019-07-17
Rev:

Company Profile